Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biomaterials

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.biomaterials.2012.09.047PMID 23122677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficient skin permeation of soluble proteins via flexible and functional nano-carrier.

  2012cited by this paper
• Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.

  2012cited by this paper
• Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.

  2011cited by this paper
• Controlled release of proteins from pluronic-based nano-carrier

  2011cited by this paper
• RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain.

  2011cited by this paper
• Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers.

  2011cited by this paper
• Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers.

  2011cited by this paper
• Diffusion and clearance of superparamagnetic iron oxide nanoparticles infused into the rat striatum studied by MRI and histochemical techniques

  2011cited by this paper
• Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

  2011cited by this paper
• Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.

  2010cited by this paper
• Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery.

  2010cited by this paper
• Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone.

  2010cited by this paper
• Self‐Assembly of Hyperbranched Polymers and Its Biomedical Applications

  2010cited by this paper
• Insulin-incorporated chitosan nanoparticles based on polyelectrolyte complex formation

  2010cited by this paper
• In-vivo tumor targeting of pluronic-based nano-carriers.

  2010cited by this paper
• Chitosan mediated targeted drug delivery system: a review.

  2010cited by this paper
• Strategy for effective brain drug delivery.

  2010cited by this paper
• Biomaterial-based technologies for brain anti-cancer therapeutics and imaging.

  2010cited by this paper
• Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.

  2009cited by this paper
• Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.

  2009cited by this paper
• Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution.

  2009cited by this paper
• Cloning, expression, purification, distribution and kinetics characterization of the bacterial beta-galactosidase fused to the cytoplasmic transduction peptide in vitro and in vivo.

  2009cited by this paper
• Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.

  2008cited by this paper
• Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier.

  2008cited by this paper
• Protein therapeutics: a summary and pharmacological classification

  2008cited by this paper
• The role of peptides in blood‐brain barrier nanotechnology

  2008cited by this paper
• One pot, single phase synthesis of thermo-sensitive nano-carriers by photo-crosslinking of a diacrylated pluronic

  2008cited by this paper
• Transvascular delivery of small interfering RNA to the central nervous system

  2007cited by this paper
• Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo.

  2006cited by this paper
• Crossing the blood-brain barrier: A potential application of myristoylated polyarginine for in vivo neuroimaging

  2005cited by this paper
• An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.

  2005cited by this paper
• TAT conjugated, FITC doped silica nanoparticles for bioimaging applications.

  2004cited by this paper
• Modulation of cellular function by TAT mediated transduction of full length proteins.

  2003cited by this paper
• Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors

  2002cited by this paper
• Protection against ischemic brain injury by protein therapeutics

  2002cited by this paper
• Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design

  2002cited by this paper
• Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier.

  2001cited by this paper
• DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs.

  2000cited by this paper
• Chitosan: a unique polysaccharide for drug delivery.

  1998cited by this paper
• Bioavailability and transport of peptides and peptide drugs into the brain.

  1997cited by this paper
• Organ targeting In vivo using phage display peptide libraries

  1996cited by this paper
• Delivery of peptides and proteins through the blood-brain barrier.

  1993cited by this paper
• Human blood-brain barrier insulin-like growth factor receptor.

  1988cited by this paper

• RVG29-Functionalized, Resveratrol-Loaded Chitosan Nanoparticles: An Inflammation-Responsive Brain-Targeted Strategy for Bipolar Disorder Therapy

  2026cites this paper
• Dual-targeted liposomes delivering ginsenoside CK attenuate cerebral ischemia-reperfusion injury by suppressing PANoptosis via O-GlcNAcylation of RIPK1/RIPK3

  2026cites this paper
• Structure, rheology, and microrheology of mixed-micelle hydrogels of PEO-PPO-PEO copolymers

  2026cites this paper
• Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis.

  2026cites this paper
• Engineered reconstructed extracellular vesicles coloaded with Astragaloside IV/Paeoniflorin improve cerebral ischemia/reperfusion injurybyinhibiting the inflammatory response.

  2025cites this paper
• Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines

  2025cites this paper
• 3D-Printed Oral Disintegrating Films of Brain-Targeted Acetyl Salicylic Acid Nanoparticles for Enhanced CNS Delivery in Ischemic Stroke

  2025cites this paper
• Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations.

  2025cites this paper
• The blood–brain barriers: novel nanocarriers for central nervous system diseases

  2025cites this paper
• Antimicrobial cyclic peptides effectively inhibit multiple forms of Borrelia and cross the blood-brain barrier model

  2025cites this paper
• Role of Galangin for the Treatment of Alzheimer’s Disease: Journey So Far and Road Ahead

  2025cites this paper
• Targeted co-delivery of IL-10 and catalase for cooperative therapeutic effect on acute kidney injury

  2025cites this paper
• Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer’s Disease

  2025cites this paper
• Treatment and early diagnosis of Parkinson's disease: Opportunities of nanotechnology

  2025cites this paper
• Advancements in Protein-Based Therapeutic Delivery Approaches Targeting the Blood-Brain Barrier and Insights on Computational Strategies.

  2025cites this paper
• Inflammation-targeted nanoplatform: NIR-II imaging-guided encephalitis suppressing by dual antioxidant-ferroptosis action.

  2025cites this paper
• Fabrication and optimization of verapamil-loaded PEGylated nanoparticles for management of traumatic brain injury: a comparative evaluation

  2025cites this paper
• Advancing Brain Targeting: Cost-Effective Surface-Modified Nanoparticles for Faster Market Entry

  2025cites this paper
• Nanotherapeutic Strategies for Overcoming the Blood–Brain Barrier: Applications in Disease Modeling and Drug Delivery

  2025cites this paper
• Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure

  2025cites this paper
• Bioengineering approaches to trained immunity: Physiologic targets and therapeutic strategies

  2025cites this paper
• Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy.

  2025cites this paper
• Research progress on mRNA drug delivery strategies in the nervous system.

  2025cites this paper
• Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

  2024cites this paper
• Scope of Nanomaterials in Treating Neurological Disorders

  2024cites this paper
• Blood brain barrier-targeted lipid nanoparticles improved the neuroprotection of Ferrostatin-1 against cerebral ischemic damage in an experimental stroke model.

  2024cites this paper
• Neuromuscular Junction Disease Modeling and Therapeutic Screening Using Zebrafish

  2024cites this paper
• Bioinspired and bioengineered nucleic acid drug carriers

  2024cites this paper
• Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases

  2024cites this paper
• Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides.

  2024cites this paper
• Bifunctional halloysite nanotube-based Ripk1 siRNA delivery system rescues cognitive impairment by targeting amyloid β plaques for clearance and reducing necrotic neurons in Alzheimer’s disease mice

  2024cites this paper
• Optimized lipopolymers with curcumin to enhance AZD5582 and GDC0152 activity and downregulate inhibitors of apoptosis proteins in glioblastoma multiforme.

  2023cites this paper
• How to Develop Drug Delivery System Based on Carbohydrate Nanoparticles Targeted to Brain Tumors

  2023cites this paper
• Biopolymers as promising vehicles for drug delivery to the brain

  2023cites this paper
• Nanomedicines to treat rare neurological disorders: The case of Krabbe disease.

  2023cites this paper
• Enhancing Opiorphin's Metabolic Stability and Preserving its Potent Analgesic Effect: A Systematic Review.

  2023cites this paper
• Neurogenic Hypertension, the Blood–Brain Barrier, and the Potential Role of Targeted Nanotherapeutics

  2023cites this paper
• Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes

  2023cites this paper
• Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes

  2023cites this paper
• Brain-targeted delivery of losartan through functionalized liposomal nanoparticles for management of neurogenic hypertension.

  2023cites this paper
• Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier

  2023cites this paper
• Targeted Glioblastoma Therapy by Integrating Brain-Targeting Peptides and Corn-derived Cancer Cell-Penetrating Proteins into Nanoparticles to Cross Blood-Brain Tumor Barriers

  2023cites this paper
• Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson’s disease by modulating α-synuclein aggregation and reactive oxygen species

  2023cites this paper
• Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma.

  2023cites this paper
• Multifunctionalized Cationic Chitosan Polymeric Micelles Polyplexed with pVGF for Noninvasive Delivery to the Mouse Brain through the Intranasal Route for Developing Therapeutics for Alzheimer's Disease.

  2023cites this paper
• Targeted nanomedicine: Lessons learned and future directions.

  2023cites this paper
• Nano Based Approach for the Neurological Disorder Treatments-A Scenario (A-Review)

  2023cites this paper
• Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

  2022cites this paper
• Chitosan chemistry review for living organisms encapsulation.

  2022cites this paper
• Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases.

  2022cites this paper
• Synthesis of N, N, N-Trimethyl Chitosan-based Nanospheres for The Prolonged Release of Curcumin

  2022cites this paper
• Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis

  2022cites this paper
• Near-Infrared Photothermally Enhanced Photo-Oxygenation for Inhibition of Amyloid-β Aggregation Based on RVG-Conjugated Porphyrinic Metal–Organic Framework and Indocyanine Green Nanoplatform

  2022cites this paper
• Brain-targeted gene delivery of ZnO quantum dots nanoplatform for the treatment of Parkinson disease

  2022cites this paper
• The influence of the blood–brain barrier in the treatment of brain tumours

  2022cites this paper
• Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia

  2022cites this paper
• Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.

  2022cites this paper
• A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics

  2022cites this paper
• Synthesis and Characterization of Fatty Acid Grafted Chitosan Polymeric Micelles for Improved Gene Delivery of VGF to the Brain through Intranasal Route

  2022cites this paper
• Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease

  2022cites this paper
• Advances in designing of polymeric micelles for biomedical application in brain related diseases.

  2022cites this paper
• Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex

  2021cites this paper
• Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood–Brain Barrier by Using Different Transport Mechanisms

  2021influential citation
• Chitin and chitosan

  2021cites this paper
• Modified biopolymer-based systems for drug delivery to the brain

  2021cites this paper
• Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide

  2021cites this paper
• Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.

  2021cites this paper
• FUNCTIONALIZED POLYMERIC NANOPARTICLES: A NOVEL TARGETED APPROACH FOR ONCOLOGY CARE

  2021cites this paper
• Rabies virus glycoprotein- and transferrin-functionalized liposomes to elevate epigallocatechin gallate and FK506 activity and mediate MAPK against neuronal apoptosis in Parkinson's disease

  2021cites this paper
• Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

  2021cites this paper
• Peptide-Chitosan Engineered Scaffolds for Biomedical Applications.

  2021cites this paper
• Nanomaterials‐Mediated Structural and Physiological Modulation of Blood Brain Barrier for Therapeutic Purposes

  2021cites this paper
• Effective and prolonged targeting of a nanocarrier to the inflammation site by functionalization with ZnBPMP and chitosan.

  2021cites this paper
• Nanotoxicity in neural regenerative medicine

  2020cites this paper
• Efficient neuronal targeting and transfection using RVG and Transferrin-conjugated liposomes.

  2020cites this paper
• The Synergistic Effect of Co-delivery of Anticancer Drugs Into Astrocytes Isolated From Human Glioblastoma Multiforme

  2020cites this paper
• Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System

  2020cites this paper
• Active targeting and transport

  2020cites this paper
• Alzheimer’s disease: review of current nanotechnological therapeutic strategies

  2020cites this paper
• Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease

  2020cites this paper
• Enteric Polymer-Coated Porous Silicon Nanoparticles for Site-Specific Oral Delivery of IgA Antibody.

  2020cites this paper
• Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.

  2020cites this paper
• Chitosan as a machine for biomolecule delivery: A review.

  2020cites this paper
• Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma.

  2020cites this paper
• Studies on Carbon Quantum Dots with Special Luminescent Properties and Their Capability of Overcoming the Biological Barriers

  2020cites this paper
• Water Disinfection Using Chitosan Microbeads With N-, C-, C-N/TiO 2 By Photocatalysis Under Visible Light

  2020cites this paper
• Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.

  2020cites this paper
• Design and validation of liposomal ApoE2 gene delivery system to evade blood-brain barrier for effective treatment of Alzheimer's disease.

  2020cites this paper
• Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers

  2020cites this paper
• Water Disinfection Using Chitosan Microbeads With N-, C-, C-N/TiO2 By Photocatalysis Under Visible Light

  2020cites this paper
• GLUT-1 an effective target to deliver BDNF gene across blood brain barrier.

  2020cites this paper
• Poloxamer: A versatile tri-block copolymer for biomedical applications.

  2020cites this paper
• Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders

  2020cites this paper
• New Developments in Medical Applications of Hybrid Hydrogels Containing Natural Polymers

  2020cites this paper
• Key for crossing the BBB with nanoparticles: the rational design

  2020cites this paper
• The Strategies of Nanomaterials for Drug Delivery and Release

  2019cites this paper
• Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier

  2019cites this paper
• The Advances of Biomacromolecule-based Nanomedicine in Brain Disease

  2019cites this paper
• Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E-/- mice.

  2019cites this paper
• In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity

  2019cites this paper